483 SpecGx Feb 2000

483 SpecGx Feb 2000

Karen Daugherty FDA, James Giefer FDA$119.00 - Available Now

FDA investigators audited the SpecGx - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 16 Feb 2000.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Feb 2000
  • Location: Saint Louis, United States
  • FEI: 1940521
Add To Cart